Developed to treat adult patients with major depressive episodes associated with bipolar I disorder, Latuda has been approved for use as monotherapy and as adjunctive therapy with either
The $1m funding will support later stage clinical trial of inhaled formulation of levodopa that is developed as an adjunct PRN therapy offering relief from intermittent debilitating motor
The first new medicine that is globally approved for newly diagnosed glioblastoma is cleared for use in combination with radiotherapy and temozolomide chemotherapy, and as monotherapy. Avastin is
Japan-based Innovation Network Corporation led the funding. PRI-724, which is currently in clinical trials for the treatment of solid tumors and leukemia, is an antiproliferative small molecule that
The new centre has the flexibility to adapt deal structures that go with early-stage needs and opportunities, and is expected to support nearly 20,000 jobs either directly or
The Swedish firm said that the new machine is equipped with a small mass detector and an advanced flash chromatography system into one commercially available platform. The mass
Formulated in cherry and grape flavors, RapiMed dissolvable pain relief remedy 80mg and 160mg tablets will be manufactured and distributed by CPI within the US and North America.
The first proof-of-concept trial is designed to study effects of the humanized antibody in subjects with renal cell carcinoma (RCC). RCC patients who failed the standard of care
R-Tech is trialing RU-101 ophthalmic solution as a severe dry eye therapy. Novozymes Biopharma marketing director Dermot Pearson said, "Novozymes is dedicated to supporting our customers in the
The contract is funded by the Defense Threat Reduction Agency (DTRA). According to the terms of the company’s contract with the Science and Technology Corporation, anti-ricin antibodies will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.